Medline (MDLN) Gross Margin (2025 - 2026)
Medline's (MDLN) quarterly Gross Margin came in at 28.82% in Q2 2026, up 116.0% year-over-year from 13.34% in Q2 2025, and up 15.1% quarter-over-quarter from 25.04% in Q1 2026.
Powered by 
Analysis
Medline (MDLN) Gross Margin (2025 - 2026) Analysis & Trends
Medline (MDLN) has reported Gross Margin for 2 consecutive years, with 28.82% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin rose 116.0% year-over-year to 28.82% in Q2 2026; TTM through Jun 2026 was 27.25%, a N/A change from a year earlier, with the FY2025 full-year figure at 26.44%, down 91.0% from the prior year.
- Gross Margin was 28.82% for Q2 2026 at Medline, up from 25.04% in the prior quarter.
- Over five years, Gross Margin peaked at 28.82% in Q2 2026 and troughed at 25.04% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 50.32 Bn | 49.46 Bn | 2.32 Bn | 46.46% |
| 2 | Medline | 48.11 Bn | 52.93 Bn | 2.22 Bn | 28.82% |
| 3 | West Pharmaceutical Services | 23.93 Bn | 23.49 Bn | 329.20 Mn | 37.74% |
| 4 | Baxter International | 13.34 Bn | 11.16 Bn | 1.03 Bn | 34.86% |
| 5 | Stevanato Group S.p.A | 6.21 Bn | 6.11 Bn | 100.91 Mn | 28.75% |
| 6 | Acme United | 241.34 Mn | 236.30 Mn | 26.69 Mn | 42.55% |
| 7 | Rockwell Medical | 31.74 Mn | 6.94 Mn | 3.24 Mn | 18.24% |
| 8 | Retractable Technologies | 21.26 Mn | -18.61 Mn | 190,852.00 | 2.65% |
| 9 | United Health Products | 12.24 Mn | 12.21 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 8.09 Mn | 4.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 28.82% |
| Mar 28, 2026 | 25.04% |
| Jun 28, 2025 | 27.66% |
| Mar 29, 2025 | 27.45% |